Cargando…

Clinical effectiveness of vortioxetine in postcovid syndrome

Detalles Bibliográficos
Autores principales:	Vikarenko, M., Vorokhta, Y., Muratova, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789434/ http://dx.doi.org/10.1016/j.nsa.2022.100316

Ejemplares similares

Postcovid Syndrome – The New Reality
por: Khoreva, M. A.
Publicado: (2022)

Postcovid-19 Asthenic Syndrome
por: Zolotovskaia, I. A., et al.
Publicado: (2022)

Neurological Signs of Postcovid Syndrome
por: Kamchatnov, P. R., et al.
Publicado: (2022)

Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program
por: Putilina, M. V., et al.
Publicado: (2022)

Features of the clinical course of ischemic stroke in postcovid patients
por: Gazieva, Shokhida, et al.
Publicado: (2021)

The probability of neurocognitive disorders in patients at the postcovid stage
por: Boev, Oleg
Publicado: (2021)

New treatment possibilities for postcovid hypogonadism and erectile dysfunction.
por: Knigavko, Oleksandr V., et al.
Publicado: (2022)

New treatment possibilities for postcovid hypogonadism and erectile dysfunction
por: Knigavko, Prof. Oleksandr V., et al.
Publicado: (2022)

Myocardial perfusion SPECT findings in postCOVID period
por: Araz, Mine, et al.
Publicado: (2021)

Potential Effect of Vortioxetine on Restless Leg Syndrome
por: Alıcı, Yasemin Hoşgören, et al.
Publicado: (2023)

PostCOVID effect on endothelial function in hypertensive patients: A new research opportunity
por: Giménez‐Miranda, Luis, et al.
Publicado: (2021)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
por: Chen, Grace, et al.
Publicado: (2017)

Reinventing Strategic Approach in Governance in Postcovid-19 Period (The Case of Saint-Petersburg in Russia)
por: Kaisarov, A. A., et al.
Publicado: (2023)

Perioperative anesthetic concerns in postcovid mucormycosis patients posted for surgical intervention: An observational Study
por: Misra, Shilpi, et al.
Publicado: (2022)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Disnea brusca de origen laríngeo: a propósito de una secuela postcovid
por: Cañibano, Rebeca de la Fuente, et al.
Publicado: (2021)

What Will Happen to Biomedical Research in Low-and-Middle Income Countries in the PostCOVID-19 World?
por: Fontecha, Gustavo, et al.
Publicado: (2021)

Diagnostische Überlegungen und therapeutische Ansätze zu PostCOVID-19 mit Chinesischer Medizin
por: Dietzel, Joanna
Publicado: (2023)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
por: Findling, Robert L., et al.
Publicado: (2017)

Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population
por: Miao, Jia, et al.
Publicado: (2019)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Emotional and psychological impact of infection and postCOVID-19 in older people: beyond the usual symptoms of long COVID
por: Martin-Lesende, Iñaki, et al.
Publicado: (2022)

EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations
por: Varisco, Benedetta, et al.
Publicado: (2023)

Cognitive effects of vortioxetine in older adults: a systematic review
por: Bishop, Makenna M., et al.
Publicado: (2021)

Effects of Vortioxetine on Sleep Architecture of Adolescents with Major Depressive Disorder
por: Mlyncekova, Zuzana, et al.
Publicado: (2023)

Effectiveness of vortioxetine in real-world clinical practice: Interim results from the relieve study
por: Mattingly, G., et al.
Publicado: (2021)

RisksAssociated with Vortioxetine in the Established Therapeutic Indication
por: Verma, Akansha, et al.
Publicado: (2021)

Lack of Effect of Vortioxetine on the Pharmacokinetics and Pharmacodynamics of Ethanol, Diazepam, and Lithium
por: Chen, Grace, et al.
Publicado: (2016)

Vortioxetine improves cognition in mild cognitive impairment
por: Tan, Sheng Neng, et al.
Publicado: (2021)

Which Cognitive Domains are Improved by Treatment with Vortioxetine?
por: Harrison, John E, et al.
Publicado: (2016)

Crystal structures of vortioxetine and its methanol monosolvate
por: Zhou, Xin-Bo, et al.
Publicado: (2015)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Evaluation of the Effect of Vortioxetine on Pain Threshold By Hot-Plate Test in Mice
por: İNALTEKİN, Ali, et al.
Publicado: (2021)

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy Individuals
por: Areberg, Johan, et al.
Publicado: (2014)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
por: Papalexi, E., et al.
Publicado: (2021)

Effectiveness of vortioxetine in real-world clinical practice: French cohort results from the global RELIEVE study
por: Polosan, M., et al.
Publicado: (2022)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvtso1df7a419bncurtdrp2cgg